424 related articles for article (PubMed ID: 6083907)
1. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907
[TBL] [Abstract][Full Text] [Related]
2. [Anti-coagulant therapy--antithrombin III].
Tsuji H
Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
[TBL] [Abstract][Full Text] [Related]
3. [Clinical aspects of acquired antithrombin III deficiency].
von Blohn G; Hellstern P; Köhler M; Scheffler P; Wenzel E
Behring Inst Mitt; 1986 Feb; (79):200-15. PubMed ID: 3718407
[TBL] [Abstract][Full Text] [Related]
4. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
Gómez C; Páramo JA; Rocha E
Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
[TBL] [Abstract][Full Text] [Related]
5. [Antithrombin III substitution in patients in shock].
Vinazzer H; Blauhut B; Bergmann H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):806-16. PubMed ID: 6083957
[TBL] [Abstract][Full Text] [Related]
6. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
Hanada T; Abe T; Takita H
Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
[TBL] [Abstract][Full Text] [Related]
9. Thrombolytic therapy for deep vein thrombosis.
Persson AV; Persson CA
Am J Surg; 1985 Oct; 150(4A):50-3. PubMed ID: 4051121
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
12. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
Sobczyk J; Swietliński J; Podleśny-Owsińska T
Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947
[No Abstract] [Full Text] [Related]
13. [Antithrombin III in 86 patients with venous thrombosis (author's transl)].
Juillet Y; Aiach M; Fiessinger JN; Leclerc M; Housset E
Sem Hop; 1978 Nov 8-15; 54(37-40):1126-9. PubMed ID: 217091
[TBL] [Abstract][Full Text] [Related]
14. Modulation of hemostatic balance with antithrombin III replacement therapy in a case of liver cirrhosis associated with recurrent venous thrombosis.
Carmassi F; Morale M; De Negri F; Carrai M
J Mol Med (Berl); 1995 Feb; 73(2):89-93. PubMed ID: 7627635
[TBL] [Abstract][Full Text] [Related]
15. [Current trends in anticoagulant and thrombolytic therapy of thrombosis].
Gavrilov OK; Rachinskaia NA; Kaveshnikova BF
Sov Med; 1975 Sep; (9):53-9. PubMed ID: 781864
[No Abstract] [Full Text] [Related]
16. [Antithrombin III activity in relation to multiple administration of various doses of heparin to normal animals].
Kudriashov BA; Pastorova VE; Liapina LA
Vopr Med Khim; 1985; 31(3):37-41. PubMed ID: 4024529
[TBL] [Abstract][Full Text] [Related]
17. [Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
Ono I
Hokkaido Igaku Zasshi; 1987 Jan; 62(1):108-21. PubMed ID: 3817736
[TBL] [Abstract][Full Text] [Related]
18. [Fibrinolytic therapy of deep venous thrombosis. Streptokinase, urokinase, plasminogen substitution].
Theiss W; Kriessmann A; Wirtzfeld A
Dtsch Med Wochenschr; 1980 Feb; 105(8):243-6. PubMed ID: 6986252
[No Abstract] [Full Text] [Related]
19. [Possibilities of drug therapy in the fight against deep venous thrombosis].
Kluken N
Phlebologie; 1981; 34(3):391-401. PubMed ID: 7291319
[TBL] [Abstract][Full Text] [Related]
20. Antithrombin III deficiency, deep venous thrombosis, and oral contraceptive use.
Werner MJ
J Adolesc Health; 1995 Sep; 17(3):189-92. PubMed ID: 8519788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
